Press Release / Media Release
December 27, 2017 Dear Sirs, Sub: Glenmark Pharmaceuticals receives ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets, 1 mg/20 mcg With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record.... Glenmark completes Phase 3 clinical trial for Ryaltris
Glenmark Pharmaceuticals has completed Phase 3 study of its investigational fixed-dose combination nasal spray and plans to submit a new drug application with the US health regulator. In a BSE... Press Release / Media Release
December 14, 2017 Dear Sirs, Sub: Glenmark Pharmaceuticals Announces Top-Line Results from a Phase 3 Safety Study Evaluating Ryaltris in Patients with Perennial Allergic Rhinitis With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record.... Glenmark Pharma begins clinical trial of anti-myeloma drug
Glenmark Pharma today said the first patient has been dosed in a phase-1 clinical trial of GBR 1342, an investigational antibody for treatment of multiple myeloma. In May this year, the US health... Press Release / Media Release
Dear Sirs, Sub: Glenmark Pharmaceuticals Announces Dosing of First Patient with Investigational Immuno-Oncology Agent GBR 1342 With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Thanking you, Yours faithfully, For Glenmark Pharmaceuticals Limited Harish Kuber Company Secretary & Compliance Officer
Glenmark gets approval for generic Seretide inhaler in Nordic region
Regulatory approval for the generic version of GlaxoSmithKline's Seretide Accuhaler in the Nordic region is Glenmark's first inhaled respiratory product approval in Europe Press Release / Media Release
Dear Sirs, Sub: Glenmark announces successful closure of the decentralised registration procedure (DCP) for generic Seretide Accuhaler in the Nordic region With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Thanking you,... Glenmark shares end marginally down
Shares of Glenmark Pharmaceuticals ended marginally lower by 0.14 per cent at Rs 571 on the BSE. The company stock opened strong at Rs 579.75 against the previous close of Rs 571.80, touched an... Updates
Sub: USFDA Audit -Baddi Unit We have to inform you that the Baddi unit of Glenmark Pharmaceuticals Limited underwent an US FDA audit from November 6, 2017 to November 11, 2017. The USFDA issued seven observations through the form 483. We are in the midst of providing a comprehensive response to the observations and would be replying to the FDA shortly on the observations.... Glenmark gets USFDA nod for contraceptive drug; shares up 0.4%
Glenmark Pharmaceuticals has received final approval from the US health regulator for a generic version of Loestrin tablets used to prevent pregnancy. Glenmark Pharmaceuticals USA has been...